Flucelvax Quadrivalent FDA Approval History
Last updated by Judith Stewart, BPharm on Sep 8, 2021.
FDA Approved: Yes (First approved May 23, 2016)
Brand name: Flucelvax Quadrivalent
Generic name: influenza virus vaccine, inactivated
Treatment for: Influenza Prophylaxis
Flucelvax Quadrivalent is an inactivated influenza vaccine indicated for active immunization for active immunization against influenza disease in people 2 years of age and older.
Development timeline for Flucelvax Quadrivalent
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.